175 related articles for article (PubMed ID: 22777646)
1. A quantitative systems approach to identify paracrine mechanisms that locally suppress immune response to Interleukin-12 in the B16 melanoma model.
Kulkarni YM; Chambers E; McGray AJ; Ware JS; Bramson JL; Klinke DJ
Integr Biol (Camb); 2012 Aug; 4(8):925-36. PubMed ID: 22777646
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-12 elicits a non-canonical response in B16 melanoma cells to enhance survival.
Byrne-Hoffman CN; Deng W; McGrath O; Wang P; Rojanasakul Y; Klinke DJ
Cell Commun Signal; 2020 May; 18(1):78. PubMed ID: 32450888
[TBL] [Abstract][Full Text] [Related]
3. Induction of Wnt-inducible signaling protein-1 correlates with invasive breast cancer oncogenesis and reduced type 1 cell-mediated cytotoxic immunity: a retrospective study.
Klinke DJ
PLoS Comput Biol; 2014 Jan; 10(1):e1003409. PubMed ID: 24426833
[TBL] [Abstract][Full Text] [Related]
4. WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition.
Deng W; Fernandez A; McLaughlin SL; Klinke DJ
J Biol Chem; 2019 Apr; 294(14):5261-5280. PubMed ID: 30723155
[TBL] [Abstract][Full Text] [Related]
5. Elimination of CD4(+) T cells enhances anti-tumor effect of locally secreted interleukin-12 on B16 mouse melanoma and induces vitiligo-like coat color alteration.
Nagai H; Hara I; Horikawa T; Oka M; Kamidono S; Ichihashi M
J Invest Dermatol; 2000 Dec; 115(6):1059-64. PubMed ID: 11121142
[TBL] [Abstract][Full Text] [Related]
6. Notch1-WISP-1 axis determines the regulatory role of mesenchymal stem cell-derived stromal fibroblasts in melanoma metastasis.
Shao H; Cai L; Moller M; Issac B; Zhang L; Owyong M; Moscowitz AE; Vazquez-Padron R; Radtke F; Liu ZJ
Oncotarget; 2016 Nov; 7(48):79262-79273. PubMed ID: 27813493
[TBL] [Abstract][Full Text] [Related]
7. Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-β1.
Yang Z; Qi Y; Lai N; Zhang J; Chen Z; Liu M; Zhang W; Luo R; Kang S
J Exp Clin Cancer Res; 2018 Jan; 37(1):1. PubMed ID: 29301578
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of interleukin-12 receptor on peripheral blood mononuclear cells and HLA class I, HLA class II or ICAM-1 on melanoma cells by B7.1 and interleukin-12: a mechanism for immunostimulatory impact of melanoma cells adenovirally transfected with B7.1 and IL12?
Yue FY; Cao L; Hemmi S; Geertsen R; Laine E; Burg G; Dummer R
Melanoma Res; 2000 Aug; 10(4):313-22. PubMed ID: 10985665
[TBL] [Abstract][Full Text] [Related]
9. CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3.
Tang Q; Jiang J; Liu J
Inflammation; 2015 Dec; 38(6):2049-56. PubMed ID: 26047948
[TBL] [Abstract][Full Text] [Related]
10. A TCM formula comprising Sophorae Flos and Lonicerae Japonicae Flos alters compositions of immune cells and molecules of the STAT3 pathway in melanoma microenvironment.
Liu YX; Bai JX; Li T; Fu XQ; Guo H; Zhu PL; Chan YC; Chou JY; Yin CL; Li JK; Wang YP; Chen YJ; Yu ZL
Pharmacol Res; 2019 Apr; 142():115-126. PubMed ID: 30797070
[TBL] [Abstract][Full Text] [Related]
11. Chrysin enhances antitumour immunity response through the IL-12-STAT4 signal pathway in the B16F10 melanoma mouse model.
Lu R; Wang S; Jiang S; Li C; Wang Y; Li L; Wang Y; Ma G; Qiao H; Leng Z; Niu J; Tian Z; Wang B
Scand J Immunol; 2022 Aug; 96(2):e13177. PubMed ID: 35484925
[TBL] [Abstract][Full Text] [Related]
12. USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity.
Hong B; Li H; Lu Y; Zhang M; Zheng Y; Qian J; Yi Q
Mol Cancer; 2014 May; 13():132. PubMed ID: 24884733
[TBL] [Abstract][Full Text] [Related]
13. Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1.
Shao H; Cai L; Grichnik JM; Livingstone AS; Velazquez OC; Liu ZJ
Oncogene; 2011 Oct; 30(42):4316-26. PubMed ID: 21516124
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy.
Ahn HM; Hong J; Yun CO
Oncotarget; 2016 Dec; 7(51):84965-84980. PubMed ID: 27821803
[TBL] [Abstract][Full Text] [Related]
15. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment.
Chelvanambi M; Fecek RJ; Taylor JL; Storkus WJ
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33526609
[TBL] [Abstract][Full Text] [Related]
16. N-propionyl-4-S-cysteaminylphenol induces apoptosis in B16F1 cells and mediates tumor-specific T-cell immune responses in a mouse melanoma model.
Ishii-Osai Y; Yamashita T; Tamura Y; Sato N; Ito A; Honda H; Wakamatsu K; Ito S; Nakayama E; Okura M; Jimbow K
J Dermatol Sci; 2012 Jul; 67(1):51-60. PubMed ID: 22622238
[TBL] [Abstract][Full Text] [Related]
17. Optimization of T-cell Receptor-Modified T Cells for Cancer Therapy.
Drakes DJ; Rafiq S; Purdon TJ; Lopez AV; Chandran SS; Klebanoff CA; Brentjens RJ
Cancer Immunol Res; 2020 Jun; 8(6):743-755. PubMed ID: 32209638
[TBL] [Abstract][Full Text] [Related]
18. CpG immunostimulatory oligodeoxynucleotide 1826 enhances antitumor effect of interleukin 12 gene-modified tumor vaccine in a melanoma model in mice.
Switaj T; Jalili A; Jakubowska AB; Drela N; Stoksik M; Nowis D; Basak G; Golab J; Wysocki PJ; Mackiewicz A; Sasor A; Socha K; Jakóbisiak M; Lasek W
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4165-75. PubMed ID: 15217954
[TBL] [Abstract][Full Text] [Related]
19. SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 and IL21, Induces Localized and Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors.
Gonzalez-Junca A; Liu FD; Nagaraja AS; Mullenix A; Lee CT; Gordley RM; Frimannsson DO; Maller O; Garrison BS; Iyer D; Benabbas A; Truong TA; Quach A; Tian M; Martinez R; Savur R; Perry-McNamara A; Nguyen D; Almudhfar N; Blanco C; Huynh C; Nand A; Lay YE; Magal A; Mangalampalli S; Lee PJ; Lu TK; Lee G
Mol Cancer Ther; 2021 Sep; 20(9):1508-1520. PubMed ID: 34210826
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor.
Björkdahl O; Dohlsten M; Sjögren HO
Cancer Gene Ther; 2000 Oct; 7(10):1365-74. PubMed ID: 11059695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
